Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Operational Study to Assess the Effectiveness, Feasibility, Acceptability, and Cost-effectiveness of the GeneXpert MTB/XDR (Xpert XDR; Cepheid) Assay for Rapid Triage-and-treatment of DR-TB

NCT05175794 is registered in ClinicalTrials.gov with Centre for the AIDS Programme of Research in South Africa as lead sponsor.

NCT NCT05175794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Operational Study to Assess the Effectiveness, Feasibility, Acceptability, and Cost-effectiveness of the GeneXpert MTB/XDR (Xpert XDR; Cepheid) Assay for Rapid Triage-and-treatment of DR-TB
Lead sponsor
Centre for the AIDS Programme of Research in South Africa
Phase
Observational
Overall status
Completed
Start date
May 26, 2022
Completion date
June 1, 2025
Enrollment
786 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

drug resistant tuberculosis, mdr-tb, tuberculosis, xdr-tb